ERIKA BURBANO: Open Payments
NPI 1184257255 · BRADENTON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$910 in 37 payments from 10 companies in 2025. Trend: 2023 $1,180 · 2024 $983 · 2025 $910
Food & beverage: $910
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $349 |
| GENZYME CORPORATION | 4 | $124 |
| GlaxoSmithKline, LLC. | 6 | $113 |
| Regeneron Healthcare Solutions, Inc. | 3 | $85 |
| Optinose US, Inc. | 3 | $82 |
| PFIZER INC. | 2 | $43 |
| PhotoniCare Inc | 1 | $41 |
| Lundbeck LLC | 2 | $37 |
| Phathom Pharmaceuticals, Inc. | 1 | $19 |
| Paratek Pharmaceuticals, Inc. | 1 | $17 |
Products named: QULIPTA, DUPIXENT, NUCALA, Xhance, UBRELVY, NURTEC ODT, OtoSight Middle Ear Scope, VYEPTI.
Industry payments across FL — which companies pay providers there.
